86 related articles for article (PubMed ID: 20698238)
21. Plasma levels of glucagon-like polypeptides in patients with esophagoplasty.
Tamburrano G; Lala A; Mauceri M; Tonelli F; Leonetti F; Andreani D
J Endocrinol Invest; 1982; 5(2):107-9. PubMed ID: 6896521
[TBL] [Abstract][Full Text] [Related]
22. Isolation and chemical characterization of glicentin C-terminal hexapeptide in porcine pancreas.
Yanaihara C; Matsumoto T; Hong YM; Yanaihara N
FEBS Lett; 1985 Sep; 189(1):50-6. PubMed ID: 4029398
[TBL] [Abstract][Full Text] [Related]
23. Evidence that glicentin contains the entire sequence of glucagon.
Holst JJ
Biochem J; 1980 May; 187(2):337-43. PubMed ID: 6893148
[TBL] [Abstract][Full Text] [Related]
24. Mouse salivary glands secrete a glucagon-degrading enzyme, not glucagon.
Baldissera FG; Poulsen K; Holst JJ
Endocrinology; 1985 Jul; 117(1):84-7. PubMed ID: 3839183
[TBL] [Abstract][Full Text] [Related]
25. Presence of glucagon-(1-21)-Like immunoreactive substance in the dog small intestinal mucosa.
Itoh H; Namba M; Watanabe N; Ohara T; Matsuyama T; Komatsu R; Shinomura Y; Kono N; Tarui S
Biochem Biophys Res Commun; 1989 Dec; 165(3):1010-7. PubMed ID: 2610678
[TBL] [Abstract][Full Text] [Related]
26. The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.
Conlon JM
Front Endocrinol (Lausanne); 2021; 12():683089. PubMed ID: 34177808
[TBL] [Abstract][Full Text] [Related]
27. Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.
Holst JJ
Diabetologia; 1983 May; 24(5):359-65. PubMed ID: 6307793
[TBL] [Abstract][Full Text] [Related]
28. Glucagon- and glicentin-immunoreactive cells in the human digestive tract.
Garaud JC; Eloy R; Moody AJ; Stock C; Grenier JF
Cell Tissue Res; 1980; 213(1):121-36. PubMed ID: 7006827
[TBL] [Abstract][Full Text] [Related]
29. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies.
Soybel D; Jaspan J; Polonsky K; Goldberg I; Rayfield E; Tager H
J Clin Endocrinol Metab; 1983 Mar; 56(3):612-8. PubMed ID: 6185527
[TBL] [Abstract][Full Text] [Related]
30. A case with glucagonoma syndrome--heterogeneity of glucagon and insulin.
Fukushima H; Yamaguchi K; Uzawa H
Endocrinol Jpn; 1981 Oct; 28(5):575-82. PubMed ID: 6284494
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like immunoreactive peptides in a rat ileal epithelial cell line (IEC-18).
Brubaker PL; Vranic M
Endocr Res; 1987; 13(3):229-41. PubMed ID: 3322805
[TBL] [Abstract][Full Text] [Related]
33. Ontogeny of glucagon-like immunoreactive peptides in rat intestine.
Brubaker PL
Regul Pept; 1987 Jun; 17(6):319-26. PubMed ID: 3602474
[TBL] [Abstract][Full Text] [Related]
34. Chemical characterization of persistent immunoreactive glucagon in eviscerated rats.
Wider MD; Dunbar JC
Acta Diabetol Lat; 1984; 21(4):341-8. PubMed ID: 6549365
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like polypeptides in canine brain.
Conlon JM; Samson WK; Dobbs RE; Orci L; Unger RH
Diabetes; 1979 Jul; 28(7):700-2. PubMed ID: 446926
[TBL] [Abstract][Full Text] [Related]
36. Content and gel filtration profiles of glucagon-like and somatostatin-like immunoreactivity in human fundic mucosa.
Holst JJ; Aggestrup S; Loud FB; Olesen M
J Clin Endocrinol Metab; 1983 Apr; 56(4):729-32. PubMed ID: 6687598
[TBL] [Abstract][Full Text] [Related]
37. Glycoprotein-like large glucagon immunoreactive species in extracts of the fetal bovine pancreas.
Tung AK; Cockburn E; Siu KP
Diabetes; 1982 Nov; 31(11):1002-5. PubMed ID: 6897390
[TBL] [Abstract][Full Text] [Related]
38. High molecular weight glucagon-like immunoreactivity in plasma.
Weir GC; Knowlton SD; Martin DB
J Clin Endocrinol Metab; 1975 Feb; 40(2):296-302. PubMed ID: 1117980
[TBL] [Abstract][Full Text] [Related]
39. [Big plasma glucagon in patients with liver cirrhosis. The discrepancy in values of immunoreactive glucagon measured by use of two different antisera against pancreatic glucagon, 30K and OAL-123].
Tsubouchi H; Kamibeppu A; Fujisaki K; Oka H; Miyazaki H; Hirono S; Hashimoto S; Nagahama J; Gohda E; Daikuhara Y
Nihon Shokakibyo Gakkai Zasshi; 1984 May; 81(5):1208-13. PubMed ID: 6471533
[No Abstract] [Full Text] [Related]
40. The normal range of the plasma immunoreactive glucagon level during a 75 g oral glucose tolerance test.
Shima K; Hirota M; Nakamura K; Kodaira T
Diabetes Res Clin Pract; 1985-1986 Feb; 1(5):265-71. PubMed ID: 3841774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
